AAV-P0-ICE

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAAV-P0-ICE

Drug Alias Namecapsase-1 gene therapy (Massachusetts General Hospital)oncolytic adeno-associated virus therapy expressing caspase-1 (Massachusetts General Hospital)AAV-P0-ICE

ClassificationBiologics > Oncolytic virus

Mechanisms of ActionCaspase-1 stimulants

TargetsCaspase-1

Therapy Area/IndicationsNeuroma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesThe General Hospital Corporation D/B/A Massachusetts General Hospital

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe General Hospital Corporation D/B/A Massachusetts General Hospital

Active IndicationsN/A

Inactive IndicationsNeuroma

Other Information

ATC CodeN/A